The NWHN Testifies for the Use of Better Evidence at the FDA

By Tessa Ruff In 2016, the FDA reclassified transvaginal mesh used to repair pelvic organ prolapse (POP) as a Class III device—the highest risk category—in response to over 20,000 adverse event reports during a three-year period alone. The NWHN actively fought for the change, which also should have required manufacturers to submit thorough, randomized safety … Continued

FDA Meeting – Surgical Mesh for Transvaginal Repair of Pelvic Organ Prolapse 

Public comments on surgical mesh for transvaginal repair of pelvic organ prolapse  [Docket No. FDA-2018-N-4395] My name is Cindy Pearson, and I am the executive director of the National Women’s Health Network. The National Women’s Health Network is a nonprofit advocacy organization that works to improve the health of all women. We bring the voices … Continued